Alcohol and GLP-1 drops Drinking alcohol while on semaglutide or tirzepatide is a topic that generates significant debate
One notable area of focus has been the identification of genetic markers associated with heart diseases
and his institution has received research grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Faraday, Gilead, Idorsia, Janssen, Matsutani Chemical Industry Co, Merck, Novartis, and the Scott R
That's roughly double what semaglutide produces and meaningfully better than tirzepatide's already-impressive Phase 3 numbers
Preliminary animal studies and small human investigations suggest GLP1s may modulate these systems, offering a rationale for further research